Sumitomo Chemical India Q2 FY27 Share Price & Earnings Call Analysis
- Market cap
- ₹16,548 Cr
- P/E
- 28.98
- ROE
- 17.65%
- PEG
- 8.88
- Price to sales
- 5.20
- Debt to equity
- 0.02
- 52W high / low
- ₹565 / ₹332
- Sales growth (5Y)
- 3.81%
- EBITDA margin
- 21.32%
- Net profit margin
- 17.40%
- Promoter holding
- 75.00%
- Sales (last year)
- ₹3,192 Cr
Sumitomo Chemical India Ltd. (SCIL) is one of the leading players in the industry which has a balanced portfolio of technical as well as formulation products along with backward integration for some products. The Company is known for domestic marketing of proprietary products of its Japanese parent -Sumitomo Chemical Company Limited in agrochemicals, animal nutrition, and environmental health business segments. With the integration of Excel Crop Care Limited, the Company now has a strong portfolio of generics in addition to specialty products and a strong combined marketing network. With this integration, the Company has moved up several notches in the pecking order of the Indian crop protection industry. SCIL has also marked its presence in Africa and several other geographies of the world.[1] [2]
Guidance scorecard · Q2 FY27 call
What Sumitomo Chemical India Ltd's management guided
and where it ranks in Fertilizers & Agrochemicals
Fertilizers & Agrochemicals
RevenueQ4 FY26 call
0–10%- FY '27 revenue growth expected to be cautious due to monsoon uncertainty, fertilizer supply, and geopolitical tensions.
- Current year (FY '27) sales targeted to be maintained around INR110-140 crores in certain segments, with no incremental revenue expected immediately from ongoing capex projects.
- Incremental revenues from capex at Dahej and other projects anticipated from FY '28 and FY '29 onwards.
- New product pipeline includes 3-4 molecules; only one (Excalia Max) launched so far with others expected in coming years post regulatory approvals.
- Specialty products are key growth drivers; contributing to 30% of domestic revenues with new technologies expected to improve volume and revenue mix structurally.
2 more points from Sumitomo Chemical India Ltd's call on revenue
Create a free account to keep reading this call
MarginsQ4 FY26 call
FlatSee what Sumitomo Chemical India Ltd said on margins — free account, 30 seconds.
CapexQ4 FY26 call
Planned- Ongoing capex projects are progressing well, especially infrastructure expansion for parent company's proprietary products, including newly launched patented products globally.
- Commitment to invest in manufacturing expansion at Bhavnagar, Tarapur, and Dahej sites.
- INR150 crores capex announced for Dahej plant, expected to commercialize within 2 years. Additional phases of similar capex size expected and will be announced periodically over next few years.
- Company is in advanced stages of techno-commercial feasibility for further capex projects; approvals pending from board and parent company.
- Capex projects aimed at becoming a manufacturing hub for parent company’s global requirements, including agro intermediates and semiconductor materials.
- Capex implementation timeline spread over multiple years, with revenue impact expected mostly beyond FY '27.
2 more points from Sumitomo Chemical India Ltd's call on capex
Create a free account to keep reading this call
FundraisingQ4 FY26 call
See what Sumitomo Chemical India Ltd said on fundraising — free account, 30 seconds.
Order bookQ4 FY26 call
- Several capex projects announced, including a significant INR150 crores capex at the Dahej site expected to commercialize in 2+ years.
- A pipeline of similar magnitude projects under feasibility studies for coming years.
- Expectation to sustain current sales (INR110-140 crores) in FY '27 with incremental revenues from capex projects likely from FY '28 onwards.
- Ongoing product registrations and launches (e.g., Excalia Max launched, others expected in FY '27).
2 more points from Sumitomo Chemical India Ltd's call on the order book
Create a free account to keep reading this call
Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.
Potential multibaggers · Q2 FY27
Potential multibaggers in Fertilizers & Agrochemicals
on management's own guidance
- Dharmaj CropGood growth2
- Anya Polytech &Good growth1
- M B Agro Prod.Good growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Peers
Fertilizers & Agrochemicals companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | Anya Polytech & | 20–40% | Up 2%+ | ₹209 Cr | 25.1 |
| 2 | Dharmaj Crop | 20–40% | Up 0–2% | ₹882 Cr | 14.7 |
| 3 | M B Agro Prod. | 20–40% | Flat | ₹7,668 Cr | 49.5 |
| 4 | 20–40% | Flat | ₹6,453 Cr | 32.8 | |
| 5 | 10–20% | Up 2%+ | ₹1,226 Cr | 18.3 | |
| 6 | 10–20% | Flat | ₹51,882 Cr | 27.8 |
Sign up free to see every company in the sector ranking and track Sumitomo Chemical India Ltd.
Pro shows every company guiding 40%+ revenue growth →Full Fertilizers & Agrochemicals rankingFinancials of Sumitomo Chemical India Ltd
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Shareholder Pattern
Sumitomo Chemical India Ltd
Shareholding breakup across reporting periods.
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters + | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% |
| FIIs + | 2.61% | 2.74% | 3.06% | 3.49% | 3.59% | 3.63% | 3.65% | 3.65% | 3.37% | 3.41% | 3.02% | 2.89% |
| DIIs + | 6.02% | 6.63% | 7.13% | 6.96% | 6.96% | 8.13% | 8.15% | 8.47% | 8.65% | 8.98% | 9.33% | 9.68% |
| Public + | 16.35% | 15.61% | 14.79% | 14.54% | 14.44% | 13.23% | 13.19% | 12.88% | 12.97% | 12.60% | 12.65% | 12.42% |
| No. of Shareholders | 1,45,083 | 1,48,764 | 1,28,148 | 1,24,857 | 1,25,812 | 1,24,650 | 1,24,950 | 1,15,793 | 1,14,878 | 1,11,892 | 1,10,464 | 1,09,118 |
Financials of Sumitomo Chemical India Ltd
Quarterly Results
Quarter-by-quarter operating performance
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 903 | 540 | 664 | 832 | 971 | 622 | 665 | 1,048 | 914 | 552 | 671 | 1,054 | 891 |
| Expenses + | 715 | 474 | 526 | 670 | 729 | 521 | 548 | 828 | 697 | 456 | 539 | 819 | 708 |
| Operating Profit | 188 | 66 | 139 | 162 | 242 | 101 | 117 | 220 | 217 | 96 | 133 | 235 | 183 |
| OPM % | 21% | 12% | 21% | 19% | 25% | 16% | 18% | 21% | 24% | 17% | 20% | 22% | 21% |
| Other Income + | 25 | 27 | 27 | 26 | 31 | 31 | 31 | 39 | 39 | 22 | 32 | 74 | 43 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
| Depreciation | 16 | 16 | 16 | 14 | 15 | 18 | 16 | 15 | 16 | 16 | 16 | 16 | 16 |
| Profit before tax | 196 | 76 | 149 | 173 | 257 | 113 | 132 | 242 | 238 | 100 | 147 | 291 | 209 |
| Tax % | 27% | 27% | 26% | 26% | 26% | 25% | 25% | 26% | 25% | 25% | 25% | 26% | 25% |
| Net Profit + | 144 | 55 | 109 | 128 | 191 | 84 | 98 | 180 | 178 | 75 | 111 | 217 | 156 |
| EPS in Rs | 2.88 | 1.10 | 2.19 | 2.57 | 3.82 | 1.69 | 1.97 | 3.60 | 3.56 | 1.50 | 2.22 | 4.34 | 3.13 |
Financials of Sumitomo Chemical India Ltd
Profit & Loss
Annual income statement trend
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 671 | 724 | 799 | 1,911 | 2,223 | 2,423 | 2,643 | 3,060 | 3,511 | 2,833 | 3,090 | 3,186 | 3,168 |
| Expenses + | 614 | 635 | 698 | 1,691 | 1,932 | 2,088 | 2,155 | 2,458 | 2,843 | 2,358 | 2,467 | 2,520 | 2,522 |
| Operating Profit | 57 | 89 | 101 | 219 | 291 | 335 | 488 | 603 | 668 | 474 | 623 | 666 | 647 |
| OPM % | 8% | 12% | 13% | 11% | 13% | 14% | 18% | 20% | 19% | 17% | 20% | 21% | 20% |
| Other Income + | 8 | 26 | 10 | 31 | -0 | -20 | 19 | 36 | 45 | 96 | 119 | 131 | 171 |
| Interest | 1 | 1 | 1 | 5 | 5 | 7 | 7 | 8 | 6 | 5 | 6 | 7 | 6 |
| Depreciation | 6 | 7 | 7 | 24 | 28 | 41 | 47 | 45 | 52 | 61 | 63 | 63 | 64 |
| Profit before tax | 58 | 107 | 103 | 221 | 258 | 267 | 453 | 586 | 655 | 503 | 674 | 727 | 747 |
| Tax % | 40% | 40% | 40% | 34% | 35% | 23% | 24% | 26% | 23% | 27% | 26% | 25% | |
| Net Profit + | 35 | 65 | 62 | 145 | 167 | 206 | 345 | 434 | 503 | 370 | 502 | 543 | 558 |
| EPS in Rs | 4.12 | 6.92 | 8.69 | 10.09 | 7.41 | 10.06 | 10.88 | 11.19 | |||||
| Dividend Payout % | 0% | 0% | 0% | 0% | 38% | 18% | 12% | 12% | 12% | 80% | 12% | 12% |
Financials of Sumitomo Chemical India Ltd
Balance Sheet
Capital structure and asset base
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 233 | 233 | 275 | 275 | 275 | 499 | 499 | 499 | 499 | 499 | 499 | 499 | 499 |
| Reserves | -2 | 63 | 360 | 665 | 761 | 710 | 1,029 | 1,425 | 1,881 | 1,941 | 2,397 | 2,885 | 3,193 |
| Borrowings + | 0 | 0 | 0 | 10 | 20 | 36 | 33 | 38 | 34 | 25 | 45 | 53 | 46 |
| Other Liabilities + | 234 | 280 | 288 | 695 | 791 | 848 | 1,097 | 1,047 | 955 | 822 | 988 | 997 | 1,198 |
| Total Liabilities | 466 | 576 | 922 | 1,644 | 1,846 | 2,093 | 2,658 | 3,009 | 3,368 | 3,287 | 3,930 | 4,434 | 4,936 |
| Fixed Assets + | 51 | 52 | 53 | 267 | 279 | 319 | 309 | 390 | 430 | 489 | 482 | 499 | 492 |
| CWIP | 0 | 1 | 7 | 9 | 8 | 10 | 14 | 35 | 71 | 23 | 28 | 20 | 21 |
| Investments | 0 | 0 | 277 | 2 | 1 | 87 | 291 | 357 | 239 | 425 | 601 | 1,226 | 1,433 |
| Other Assets + | 415 | 523 | 585 | 1,367 | 1,558 | 1,676 | 2,043 | 2,227 | 2,628 | 2,351 | 2,819 | 2,690 | 2,991 |
| Total Assets | 466 | 576 | 922 | 1,644 | 1,846 | 2,093 | 2,658 | 3,009 | 3,368 | 3,287 | 3,930 | 4,434 | 4,936 |
Financials of Sumitomo Chemical India Ltd
Cash Flows
Operating, investing and financing cash movement
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 4 | 52 | -21 | 49 | 75 | 222 | 424 | 223 | 389 | 756 | 458 | 443 |
| Cash from Investing Activity + | -8 | -5 | -289 | -40 | -35 | -118 | -282 | -281 | -327 | -426 | -405 | -329 |
| Cash from Financing Activity + | 0 | -0 | 276 | 7 | -65 | -61 | -47 | -63 | -73 | -331 | -65 | -81 |
| Net Cash Flow | -4 | 47 | -34 | 16 | -26 | 43 | 95 | -120 | -10 | -1 | -11 | 33 |
| Free Cash Flow | -6 | 44 | -310 | 6 | 36 | 184 | 382 | 111 | 270 | 695 | 431 | 404 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 44% | 102% | 14% | 60% | 56% | 90% | 109% | 61% | 83% | 187% | 100% | 91% |
Financials of Sumitomo Chemical India Ltd
Ratios
Working capital efficiency and return ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 83 | 92 | 101 | 105 | 110 | 128 | 117 | 101 | 98 | 91 | 90 | 81 |
| Inventory Days | 135 | 169 | 191 | 202 | 193 | 133 | 185 | 198 | 157 | 135 | 154 | 166 |
| Days Payable | 109 | 132 | 115 | 176 | 136 | 112 | 145 | 110 | 87 | 96 | 107 | 86 |
| Cash Conversion Cycle | 109 | 130 | 177 | 131 | 167 | 150 | 157 | 189 | 168 | 131 | 136 | 161 |
| Working Capital Days | 69 | 79 | 113 | 113 | 116 | 109 | 95 | 127 | 136 | 173 | 183 | 155 |
| ROCE % | 27% | 41% | 22% | 29% | 27% | 26% | 33% | 34% | 30% | 21% | 25% | 23% |
Guidance history
How Sumitomo Chemical India Ltd's guidance has moved, call by call
| Call | Revenue | Margins | Capex | Fundraising | Order book |
|---|---|---|---|---|---|
| Q4 FY26 call → | 0–10% | Flat | Planned | — | — |
| Q2 FY26 call → | 10–20% | Flat | Planned | — | — |
What management guided on each call, newest first. Not investment advice, and not a forecast of returns.
Momentum score · price trend
7 out of 100 — Cooling
Over the past year its share price has done worse than most of the stocks we track.
| Period | Share price change | Better than … of 1,910 stocks |
|---|---|---|
| Last 12 months | −34.5% | 17% |
| Last 6 months | −20.8% | 17% |
| Last 3 months | −34.7% | 2% |
The price is 47.4% below its all-time high of ₹630.65 (1 Aug 2025). Stocks more than 20% below their peak have their score halved, so 14 became 7.
How we calculate it
“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).
The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Sumitomo Chemical India Ltd: 0.4 × 17 + 0.4 × 17 + 0.2 × 2 = 14, halved to 7 because the price is more than 20% below its all-time high.
Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.
Full methodology →This describes only how the share price has moved up to 29 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.
Continue your research
What Sumitomo Chemical India Ltd's management said in earlier quarters
- Q2 FY27 earnings call analysis →
- Q3 FY24 earnings call analysis →
- Q1 FY25 earnings call analysis →
- Q3 FY25 earnings call analysis →
- Q4 FY25 earnings call →
- Q2 FY25 earnings call →
- Q4 FY24 earnings call →
- Q2 FY24 earnings call →
- Q4 FY23 earnings call →
- Q2 FY23 earnings call →
- Q4 FY22 earnings call →
- Q2 FY22 earnings call →
Others in Fertilizers & Agrochemicals this season
- Dhanuka Agritech Ltd (Q2 FY27)
657.51 Crores . Key investor presentation takeaways from Dhanuka Agritech Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers.
- Sharda Cropchem Ltd (Q2 FY27)
1,051.7 Cr, up 13% YoY (Q2 FY26: Rs. Key investor presentation takeaways from Sharda Cropchem Ltd's Q2 FY27 investor presentation — and how it ranks against sec
- Paradeep Phosphates Ltd (Q2 FY27)
Revenue from operations for the quarter ended 30 September 2026: Rs 7,164.06 crores . Key results statement takeaways from Paradeep Phosphates Ltd's Q2 FY27 ear
- Astec Lifescienc (Q2 FY27)
2.3% YoY decline. Key results statement takeaways from Astec Lifescienc's Q2 FY27 results statement — and how it ranks against sector peers.